IndiaTickerLatest filing: General Updates - Jubilant Pharmova Limited
ObservedCompany dossier
Jubilant Pharmova
NSE:JUBLPHARMA · ISIN INE700A01033
- Close
- ₹977.4 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Jubilant Pharmova
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹1,821.7 Cr · PAT ₹100.7 Cr.
Exchange XBRLLatest ownership: promoter group 47.68% and public 51.77% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing General Updates - Jubilant Pharmova Limited
NSE · exchange filing
Observed
Source filing Jubilant Pharmova Ltd - 530019 - Submission Of Copies Of Newspaper Publications - Annual General Meeting Of Jubilant Pharmova Limited Scheduled To Be Held On Wednesday, August 26, 2026 Through Video Conferencing/Other Audio Visual Means.
BSE · exchange filing
Observed
Source filing General Updates - Jubilant Pharmova Limited
NSE · exchange filing
Observed
Source filing Shareholders meeting - Jubilant Pharmova Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹1,821.7 Cr
- Profit after tax
- ₹100.7 Cr
- EPS
- ₹6.37
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 47.68%
- Public
- 51.77%
- Employee trust
- 0.55%
Observed NSE shareholding XBRL